Welcome to December Hotel Okura Tokyo, Japan

Size: px
Start display at page:

Download "Welcome to December Hotel Okura Tokyo, Japan"

Transcription

1 Welcome to 9 10 December 2013 Hotel Okura Tokyo, Japan

2 What is CASSS? Non-profit professional membership society that provides networking and peer-to-peer learning opportunities for professionals involved in the development and regulation of biopharmaceutical products worldwide. Annually CASSS symposia attract over 1,800 participants from more than 20 countries; who, on average, have nearly 10 years of experience in their jobs. Our symposia range in size from approximately 125 to 600 attendees, providing a collegial atmosphere that gives people ample opportunity to interact and network with everyone. Our goal is for CASSS to be known as the place where you gain the knowledge and the contacts to help you bring biopharmaceutical medicines to those who need them more quickly, safely and for less cost Highlights include: 11 Symposia, including 2 nd Annual CMC Strategy Forum Japan Awarded over $33,000 in Student Travel Grants; 37 students awarded 135 Volunteers serving on Scientific Organizing Committees

3 CASSS Family of Meetings CMC Strategy Forum January 27, 2014 Mayflower Renaissance Hotel Washington, DC 18 th Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products January 28 30, 2014 Mayflower Renaissance Hotel Washington, DC

4 CASSS Family of Meetings 3rd International Symposium on Higher Order Structure of Protein Therapeutics February 18 20, 2014 Crystal City Marriott at Reagan National Airport, Arlington, Virginia Scientific Approaches & Regulatory Strategies March 24 25, 2014 Sheraton Silver Spring Hotel Silver Spring, Maryland

5 CASSS Family of Meetings CMC Strategy Forum Europe 5 7 May 2014 Hilton Sorrento Palace Sorrento, Italy CMC Strategy Forum July 21 22, 2014 Gaithersburg Marriott Washingtonian Center Gaithersburg, Maryland

6 CASSS Family of Meetings Symposium on the Practical Applications of Mass Spectrometry September 9 12, 2014 Silverado Hotel Napa, California CE in the Biotechnology & Pharmaceutical Industries October 12-16, 2014 Hyatt at Olive 8 Seattle, Washington

7 CASSS Family of Meetings CMC Strategy Forum Japan 2014 December 8-9, 2014 Tokyo, Japan

8 CASSS Family of Meetings CMC Strategy Forum LATAM 2014 August 2014 Exact Date TBD Brasilia, Brazil

9 In addition Support students and postdocs to attend CASSS sponsored meetings Maintain archive of all CMC Strategy Forum summary papers On-line Career Center post resume/cv, create job alerts and search hundreds of jobs

10 Find out more

11 Welcome to 9 10 December 2013 Hotel Okura Tokyo, Japan

12 Mission Statement Provide a venue biotechnology/biological product discussion that focuses on relevant CMC issues throughout the lifecycle of the product Foster collaborative technical and regulatory interactions Share information with the regulatory agencies to assist them in merging good scientific and regulatory practices

13 CMC Forum History The CMC Strategy Forum was launched in 2002 from the well established WCBP Symposium To date, 30 Forums have been held in the US (typically 3 per year) resulting in the publication of over 24 white papers on a wide variety of CMC topics The CMC Forum Europe was launched in 2007 with support from the Biotech Working Party/EMA and quickly became a successful annual event

14 Find out more about past CMC Strategy Forums Look under ARCHIVES for past Forum information and publications.

15 CMC Forum Format The Forum has two components: - presentations (frame the discussion) - Workshops where open dialogue and exchange of ideas among participants is highly encouraged Typically each workshop will address about 3 specific questions related to a given topic The workshop success is dependent on active engagement of the participants Questions can be asked in either Japanese or English simultaneous translation

16 Japan Scientific Program Organizing Committee Kimio Esumi, Japan Pharmaceutical Manufacturers Association (JPMA) (Secretariat) Futaba Honda, Pharmaceuticals and Medical Devices Agency (PMDA) Yasuhiro Kishioka, Pharmaceuticals and Medical Devices Agency (PMDA) Junichi Koga, Daiichi Sankyo Co., Ltd. Tetsuya Kusakabe, Pharmaceutical and Medical Devices Agency (PMDA) In Eui Lee, Chugai Pharmaceutical Co., Ltd. Hisako Ohnishi, Japan Pharmaceutical Manufacturers Association (JPMA) (Secretariat) Jun Sakamoto, Pharmaceutical and Medical Devices Agency (PMDA) Yoichiro Shiba, Daiichi Sankyo Co., Ltd. Yasushi Shikata, Eisai Co., Ltd. Kazuhisa Uchida, Kyowa Hakko Kirin Co., Ltd. Toyohiko Yamamoto, Asahi Kasei Pharma Corp. Reiko Yanagihara, Pharmaceutical and Medical Devices Agency (PMDA)

17 CMC Strategy Forum Global Steering Committee Siddharth Advant, ImClone Systems Corporation, USA John Dougherty, Eli Lilly and Company, USA Christopher Joneckis, CBER, FDA, USA Rohin Mhatre, Biogen Idec, USA Anthony Mire-Sluis, Amgen Inc., USA Wassim Nashabeh, Genentech, a Member of the Roche Group, USA Ilona Reischl, BASG / AGES, Austria Anthony Ridgway, Health Canada, Canada Nadine Ritter, Biologics Consulting Group, Inc., USA Mark Schenerman, MedImmune, USA Thomas Schreitmüller, F. Hoffmann-La Roche Ltd., Switzerland Karin Sewerin, BioTech Development AB, Sweden

18 Forum Program Partners Baxter Limited Chugai Pharmaceutical Co., Ltd. Daiichi Sankyo Co., Ltd. Eisai Co., Ltd. Kissei Pharmaceutical Co., Ltd. Kyowa Hakko Kirin Co., Ltd. Mitsubishi Tanabe Pharma Corporation Nippon Boehringer Ingelheim Co., Ltd. Nippon Kayaku Co., Ltd. Shionogi & Co., Ltd. Takeda Pharmaceutical Company Limited Zeria Pharmaceutical Co., Ltd.

19 Sustaining Diamond Program Partner Genentech, a Member of the Roche Group Sustaining Platinum Program Partner Biogen Idec

20 Leading Media Partners BioProcess International International Pharmaceutical Quality Media Partners Analyst The Analytical Scientist BioProcessing Journal Bio Tech International Genetic Engineering & Biotechnology News Technology Networks Limited Wiley/Journal of Separation Science

21 CMC Strategy Forum Japan 2013 Attendees pre-registered Number of regulators pre-registered 20 Number of companies represented 45 Number of countries represented 14 (Austria, Canada, China, Denmark, Finland, Germany, India, Japan, Singapore, South Korea, Switzerland, Taiwan, United Kingdom, USA)

22 Special Thanks to Michael Johnstone, MJ Audio Visual Productions CASSS Staff: Karen Bertani, Director of Meetings Stephanie Flores, Executive Director Anna Lingel, Project Coordinator Linda Mansouria, Manager of Meetings and Events Renee Olson, Senior Program Manager Catherine Stewart, Finance Director

23 Reminders and Announcements Please remember to be courteous by turning all cell phones off and refraining from conversations in the meeting rooms 17:30 19:00 Networking Reception Evaluation form we ve gone GREEN - online link will be sent to your on Wednesday, 11 December don t forget to complete and hit SUBMIT

Welcome to. January 26, The Mayflower Hotel Washington, DC USA

Welcome to. January 26, The Mayflower Hotel Washington, DC USA Welcome to January 26, 2015 The Mayflower Hotel Washington, DC USA Mission Statement Provide a venue for biotechnology/biological product discussion that focuses on relevant CMC issues throughout the lifecycle

More information

Welcome to the CMC Strategy Forum

Welcome to the CMC Strategy Forum Welcome to the CMC Strategy Forum We are pleased to welcome you to the CMC Strategy Forum. The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion. The

More information

Welcome to the CMC Strategy Forum Prior Knowledge: Learning from Our Successes and Failures to Improve Product Development and Manufacturing

Welcome to the CMC Strategy Forum Prior Knowledge: Learning from Our Successes and Failures to Improve Product Development and Manufacturing Welcome to the CMC Strategy Forum Prior Knowledge: Learning from Our Successes and Failures to Improve Product Development and Manufacturing We are pleased to welcome you to the CMC Strategy Forum. The

More information

Welcome to the CMC Strategy Forum Phase-appropriate Method Validation Strategies: Policies and Practices to Support Clinical Development

Welcome to the CMC Strategy Forum Phase-appropriate Method Validation Strategies: Policies and Practices to Support Clinical Development Welcome to the CMC Strategy Forum Phase-appropriate Method Validation Strategies: Policies and Practices to Support Clinical Development We are pleased to welcome you to the CMC Strategy Forum. The purpose

More information

Welcome to the CMC Strategy Forum Europe 2017

Welcome to the CMC Strategy Forum Europe 2017 Welcome to the CMC Strategy Forum Europe 2017 The 11 th annual CMC Strategy Forum Europe, organized by CASSS, will explore a number of critical topics focused on improving the quality in development and

More information

Welcome to the CMC Strategy Forum Europe 2018

Welcome to the CMC Strategy Forum Europe 2018 Welcome to the CMC Strategy Forum Europe 2018 The 12 th annual CMC Strategy Forum Europe, organized by CASSS, will explore many critical topics focused on improving the quality in development and manufacturing

More information

Welcome to the CMC Strategy Forum

Welcome to the CMC Strategy Forum Welcome to the CMC Strategy Forum We are pleased to welcome you to the CMC Strategy Forum. The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion. The

More information

Welcome to the CMC Strategy Forum (July 20-21, 2016)

Welcome to the CMC Strategy Forum (July 20-21, 2016) Welcome to the CMC Strategy Forum (July 20-21, 2016) We are pleased to welcome you to the CMC Strategy Forum. The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product

More information

Experiences of a Bioinformatics Company in. Dr Othmar Pfannes 4 November 2016 Basel

Experiences of a Bioinformatics Company in. Dr Othmar Pfannes 4 November 2016 Basel Experiences of a Bioinformatics Company in Dr Othmar Pfannes 4 November 2016 Basel Agenda About Genedata Genedata in Japan Q&A 2 Genedata Snapshot Roots Established in 1997 Privately owned Headquartered

More information

World s Leading Pharmaceutical R&D and Manufacturing Trade Show

World s Leading Pharmaceutical R&D and Manufacturing Trade Show World s Leading Pharmaceutical R&D and Manufacturing Trade Show Dates: June 29(Wed)-July 1(Fri), 2016Venue: Tokyo Big Sight, Japan Organised by : Reed Exhibitions Japan Ltd. Concurrent Shows: in-pharma

More information

As defined in the US Code of

As defined in the US Code of Technical B i op r o c e s s The Roles of Bioactivity Assays in Lot Release and Stability Testing by Noel Rieder, Hélène Gazzano-Santoro, Mark Schenerman, Robert Strause, Chana Fuchs, and Anthony Mire-Sluis,

More information

The first CMC Strategy Forum

The first CMC Strategy Forum B i op r o c e s s Technical Quality by Design: The Next Phase Potential Regulatory Implications and Filing of QbD Data Anthony Mire-Sluis, Mark Schenerman, Rohin Mhatre, Siddharth Advant, John Dougherty,

More information

The State of QbD in the Biopharmaceutical Industry Conference

The State of QbD in the Biopharmaceutical Industry Conference The State of QbD in the Biopharmaceutical Industry Conference Criticality Assessment, Design Space Implementation and Control 10 11 April 2013 Sheraton Fisherman s Wharf San Francisco, California USA Sponsored

More information

Multiproduct Facility Design and Control for Biologics

Multiproduct Facility Design and Control for Biologics F l e x-faci liti es Design Multiproduct Facility Design and Control for Biologics Challenges and Considerations Bo Chi, Julia Edwards, Jun Park, Stefanie Pluschkell, Nancy Waites, Elizabeth Yamashita,

More information

Innovation for Pharma to engage with the mobile user.

Innovation for Pharma to engage with the mobile user. www.healthnetworkcommunications.com/mobile Innovation for Pharma to engage with the mobile user 24-27 April 2012 Sheraton Hotel, Amsterdam, The Netherlands created by sponsor endorsed by Smart phones and

More information

The number of biotherapeutics on

The number of biotherapeutics on B i op r o c e s s Technical Analysis and Immunogenic Potential of Aggregates and Particles A Practical Approach, Part 1 Anthony Mire-Sluis, Barry Cherney, Russell Madsen, Alla Polozova, Amy Rosenberg,

More information

The 15th WCBP CMC Strategy

The 15th WCBP CMC Strategy B i op r o c e s s Technical Raw Material Control Strategies for Bioprocesses by Gregory Beck, Mark Schenerman, John Dougherty, Ruth Cordoba-Rodriguez, Christopher Joneckis, Anthony Mire-Sluis, and Lorna

More information

4 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2015)

4 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2015) 4 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2015) Symposium Co-chairs: Jamie Moore, Genentech, a Member of the Roche Group Linda Narhi, Amgen Inc. April 13-15, 2015

More information

Post-approval Change Management Protocols - Current Status and Next Steps on the Way towards a Global Tool

Post-approval Change Management Protocols - Current Status and Next Steps on the Way towards a Global Tool Post-approval Change Management Protocols - Current Status and Next Steps on the Way towards a Global Tool Dr. Markus Goese Lead EU CMC Regulatory Policy F. Hoffmann-La Roche Ltd, Basel - Switzerland Presentation

More information

Welcome to the CMC Strategy Forum Europe 2009: CMC Perspectives on Biological Investigational Medicinal Products in Clinical Trials

Welcome to the CMC Strategy Forum Europe 2009: CMC Perspectives on Biological Investigational Medicinal Products in Clinical Trials Welcome to the CMC Strategy Forum Europe 2009: CMC Perspectives on Biological Investigational Medicinal Products in Clinical Trials The organizers of the CMC Strategy Forum Europe, sponsored by CASSS,

More information

The 13th WCBP CMC Strategy

The 13th WCBP CMC Strategy FOCUS ON... DIsposableS Extractables and Leachables Challenges and Strategies in Biopharmaceutical Development Anthony Mire-Sluis, Stacey Ma, and Ingrid Markovic, with Lorna McLeod The 13th WCBP CMC Strategy

More information

Immunotoxicology Technical Committee (ITC) HESI Assembly of Members January 19, 2009

Immunotoxicology Technical Committee (ITC) HESI Assembly of Members January 19, 2009 Immunotoxicology Technical Committee (ITC) HESI Assembly of Members January 19, 2009 Committee Leadership Dr. Ellen Evans (Schering-Plough Research Institute), Chair Dr. Tom Kawabata (Pfizer Inc.), Vice

More information

GLOBAL COALITION FOR GOOD WATER GOVERNANCE

GLOBAL COALITION FOR GOOD WATER GOVERNANCE GLOBAL COALITION FOR GOOD WATER GOVERNANCE Launched at the 2016 World Water Week in Stockholm, Sweden The OECD Principles on Water Governance On 4 June 2015, the OECD Principles on Water Governance were

More information

Welcome to the CMC Strategy Forum Europe 2014 Improving Biopharmaceutical Product Quality: Moving Implementation Forward

Welcome to the CMC Strategy Forum Europe 2014 Improving Biopharmaceutical Product Quality: Moving Implementation Forward Welcome to the CMC Strategy Forum Europe 2014 Improving Biopharmaceutical Product Quality: Moving Implementation Forward The eighth annual CMC Strategy Forum Europe, organized by CASSS - An International

More information

The Corporate Representative's Presentation

The Corporate Representative's Presentation The Corporate Representative's Presentation IFCC General Conference, Madrid, 2016-03-19 Rolf Hinzmann, MD, PhD Corporate Representative at the IFCC Executive Board Contact: rolf.hinzmann@roche.com Agenda

More information

14th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2017)

14th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2017) 14th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2017) Symposium Co-Chairs: Michael Boyne, BioTechLogic, Inc. Eef Dirksen, Synthon Biopharmaceuticals

More information

Modern Approaches to Process Understanding

Modern Approaches to Process Understanding Biomanufacturing and Process Development (BPD) Modern Approaches to Process Understanding Thursday, September 18, 2014 1:00 pm - Registration begins 1:15 5:00 pm - Presentations & Networking North Carolina

More information

Global Biologics Regulatory Trends Challenges and Opportunities..

Global Biologics Regulatory Trends Challenges and Opportunities.. Global Biologics Regulatory Trends Challenges and Opportunities.. Wassim Nashabeh VP, Regulatory Policy and International Operations F.Hoffmann La-Roche, Basel, Switzerland picture placeholder Page 2 N-linked

More information

Global Oncology Biosimilars Market

Global Oncology Biosimilars Market Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Oncology Biosimilars Market 2016-2020 Global Oncology Biosimilars Market 2016-2020 Publication ID: TNV0216071

More information

Investigating Clinical Trial Costs Comparative Analysis of Trial Cost Components in Key Geographies Table of Contents

Investigating Clinical Trial Costs Comparative Analysis of Trial Cost Components in Key Geographies Table of Contents Investigating Clinical Trial Costs Comparative Analysis of Trial Cost Components in Key Geographies Table of Contents Executive summary 14 Introduction and background to clinical trials 14 Financial considerations

More information

Serving the dynamic informational and networking needs of the global healthcare and life sciences ecosystem for over a decade

Serving the dynamic informational and networking needs of the global healthcare and life sciences ecosystem for over a decade Calendar 2018 Serving the dynamic informational and networking needs of the global healthcare and life sciences ecosystem for over a decade For more information on sponsoring, exhibiting, speaking or attending

More information

MEDIUS PARTNERING. July Global specialist provider of Business Development services to the Pharmaceutical and Healthcare Sectors

MEDIUS PARTNERING. July Global specialist provider of Business Development services to the Pharmaceutical and Healthcare Sectors MEDIUS PARTNERING July 2017 Global specialist provider of Business Development services to the Pharmaceutical and Healthcare Sectors Medius Associates Healthcare Business Development consultancy founded

More information

CENTRAL NERVOUS SYSTEM (CNS) BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS

CENTRAL NERVOUS SYSTEM (CNS) BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS CENTRAL NERVOUS SYSTEM (CNS) : TECHNOLOGIES AND GLOBAL MARKETS BIO074C March 2016 Jackson Highsmith Project Analyst ISBN: 1-62296-246-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215

More information

ANALYTICAL STANDARDS AND REAGENTS

ANALYTICAL STANDARDS AND REAGENTS ANALYTICAL STANDARDS AND REAGENTS productivity future growth globalization compliance Waters, the industry leader in liquid chromatography and mass spectrometry, understands that standards and reagents

More information

Application from the World Federation of Chinese Medicine Societies for admission into official relations with WHO

Application from the World Federation of Chinese Medicine Societies for admission into official relations with WHO EXECUTIVE BOARD EB136/NGO/6 136th session 6 November 2014 Provisional agenda item 13.3 Application from the World Federation of Chinese Medicine Societies for admission into official relations with WHO

More information

Current Status of Pharmaceutical Patenting at United States Patent Office Rau. B. S Appaji P. V

Current Status of Pharmaceutical Patenting at United States Patent Office Rau. B. S Appaji P. V Current Status of Pharmaceutical Patenting at United States Patent Office Rau. B. S Appaji P. V Abstract: Indian pharmaceutical industry has proved manufacture of global quality pharmaceutical products

More information

International Association for Biologicals

International Association for Biologicals International Association for Biologicals Presentation to Japanese Biologicals Forum by Tony Lubiniecki Tokyo, 16January2008 Scientific Society established in 1955 Headquartered in Switzerland Recognized

More information

UPDATE OF CEM FURTHER EVENTS AND CHP/DHC WORKING GROUP

UPDATE OF CEM FURTHER EVENTS AND CHP/DHC WORKING GROUP UPDATE OF CEM FURTHER EVENTS AND CHP/DHC WORKING GROUP CLEAN ENERGY MINISTERIAL CHP/DHC WORKING GROUP INTERNATIONAL ENERGY AGENCY CHP/DHC COLLABORATIVE JOINT WORKSHOP 26 27 TH NOVEMBER, 2013 HELSINKI,

More information

Technical Report No. 60 Process Validation: A Lifecycle Approach

Technical Report No. 60 Process Validation: A Lifecycle Approach Technical Report No. 60 Process Validation: A Lifecycle Approach Paradigm Change in Manufacturing Operations SM PDA Task Force on Technical Report No. 60: Process Validation: A Lifecycle Approach Authors

More information

HOW TO SETUP JOB ALERTS

HOW TO SETUP JOB ALERTS HOW TO SETUP JOB ALERTS When you create a profile and/or apply for a job, you are able to set-up your Job Alert preferences to receive notifications when jobs are posted that match your interests. Please

More information

Working together to meet global energy challenges

Working together to meet global energy challenges Working together to meet global energy challenges Staff on loan From around the world From IEA and OECD member countries: Australia Austria Belgium Canada Chile Czech Republic Denmark Estonia Finland France

More information

innovative unrivalled committed inspirational international

innovative unrivalled committed inspirational international innovative unrivalled committed inspirational international innovative unrivalled committed inspirational WorldSkills is a powerful means for building a global skills respect culture. It enables the best

More information

Bayer s Contribution to a Healthier Society

Bayer s Contribution to a Healthier Society Bayer s Contribution to a Healthier Society 12th Japan-Germany Industry Forum in Tokyo Dec. 1 st, 2016 / Hans-Dieter Hausner, President and Senior Bayer Representative at Bayer Holding Ltd. Our Mission

More information

MEETING AGENDA September 2006

MEETING AGENDA September 2006 MEETING AGENDA 6 th IPHE Steering Committee Meeting 25 27 September 2006 2 nd Draft Nordica Hotel Sudurlandsbraut 2, Reykjavik, Iceland Room Registration: https://secures7.brinkster.com/bjarkiek/iphi.asp

More information

BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS

BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS : TECHNOLOGIES AND GLOBAL MARKETS BIO061C April 2014 Jackson Highsmith Project Analyst ISBN: 1-56965-801-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free within

More information

Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2015)

Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2015) Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2015) Symposium Co-Chairs: Cari Sänger - van de Griend, Kantisto

More information

Market Report Biopharmaceuticals and Biosimilars

Market Report Biopharmaceuticals and Biosimilars Market Report Biopharmaceuticals and Biosimilars December, 2017 **Disclaimer of Warranties** While JETRO makes every effort to ensure that we provide accurate information and advice regarding laws and

More information

APAC Harmonization: New Activities

APAC Harmonization: New Activities APAC Harmonization: New Activities CMC Strategy Forum Japan 2013 December 09, 2013 Japan Pharmaceutical Manufacturers Association (JPMA) Kozo Akasaka 1 Agenda 0. What is APAC? 1. Collaboration of JPMA

More information

SPONSOR + EXHIBITOR PACKAGES

SPONSOR + EXHIBITOR PACKAGES THE 7TH ANNUAL CHIROPRACTIC EVENT OF THE YEAR AN IDEA WHOSE TIME HAS COME SPONSOR + EXHIBITOR PACKAGES SAN FRANCISCO August 4-6, 2017 www.lifewestwave.com A MESSAGE FROM DR. RONALD OBERSTEIN Dr. Ronald

More information

US FDA and International Regulatory Efforts in Cellular and Gene Therapies

US FDA and International Regulatory Efforts in Cellular and Gene Therapies US FDA and International Regulatory Efforts in Cellular and Gene Therapies ISCT Satellite Global Regulatory Perspectives Workshop January 27, 2013 Kimberly Benton, Ph.D. Deputy Director, Division of Cellular

More information

Product Catalog # Description List Price (JPY) Primer Assays (desalted)

Product Catalog # Description List Price (JPY) Primer Assays (desalted) Assays and Controls Primer Assay Pricing Primer Assays (desalted) 10025636 Primer assay desalted, 200 reactions 16,000 (Wet-lab validated human, mouse, and rat) 10025637 Primer assay desalted, 1,000 reactions

More information

EVOLUTION OF THE LABOUR MARKET WORKFORCE AND DIVERSITY TRAINING VOLUNTARY WORK ENVIRONMENT

EVOLUTION OF THE LABOUR MARKET WORKFORCE AND DIVERSITY TRAINING VOLUNTARY WORK ENVIRONMENT CSR INDICATORS WITH THE PUBLICATION OF ITS FIRST CSR REPORT, GI GROUP WILL PRESENT TO ALL ITS STAKEHOLDERS THE PLAN FOR THE CREATION OF ITS OWN CSR INTERNATIONAL SYSTEM. 72 In this chapter the main indicators

More information

Siemens Partner Program

Siemens Partner Program Siemens Partner Program Factory Automation Partner Strategy for Factory Automation End Customer Focus on core competencies Demand on efficient solutions Certified Partner Added value in solutions and services

More information

Symposium Co-Chairs: Steffen Kiessig, F. Hoffmann La Roche Ltd. David Michels, Genentech, a Member of the Roche Group

Symposium Co-Chairs: Steffen Kiessig, F. Hoffmann La Roche Ltd. David Michels, Genentech, a Member of the Roche Group CE in the Biotechnology & Pharmaceutical Industries: 19 th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides and Small Molecules (CE Pharm 2017) Symposium Co-Chairs: Steffen

More information

Economic and Social Council

Economic and Social Council United Nations E/CN.3/2008/20 Economic and Social Council Distr.: General 7 December 2007 Original: English Statistical Commission Thirty-ninth session 26-29 February 2008 Item 4 (f) of the provisional

More information

Connecting People, Science and Regulation

Connecting People, Science and Regulation Connecting People, Science and Regulation Bethesda Towers 4350 East West Highway, Ste 600 Bethesda, MD 20814 USA Tel: +1 (301) 656-5900 Fax: +1 (301) 986-0296 www.pda.org PDA Europe ggmbh Am Borsigturm

More information

Communication Business Partner PHC CoE

Communication Business Partner PHC CoE Date: 02/28/18 Communication Business Partner PHC CoE Job ID: 3594886658 Job Function Employee Communications Location United States - California South San Francisco Company/Division Pharmaceuticals Schedule

More information

Patients are Counting on Us: It s Time to Act

Patients are Counting on Us: It s Time to Act Patients are Counting on Us: It s Time to Act Brian Johnson Chairman Rx-360 Senior Director Supply Chain Security Pfizer, Inc. 24 th Global GS1 Healthcare Conference October 2, 2013 THE WALL STREET JOURNAL

More information

The European Medical Technology Industry. in figures / 2018

The European Medical Technology Industry. in figures / 2018 The European Medical Technology Industry in figures / 2018 Table of contents What is Medical Technology? 4 Innovation 10 Employment 14 Companies 18 Expenditure on Medical Technology 20 MedTech Market in

More information

Paradigm Change in Manufacturing Operations

Paradigm Change in Manufacturing Operations Technical Report No. 56 (Revised 2016) Application of Phase-Appropriate Quality System and cgmp to the Development of Therapeutic Protein Drug Substance (API or Biological Active Substance) Paradigm Change

More information

PHARMACEUTICAL & BIOTECHNOLOGY QUALITY CONTROL. Early Investment in Characterization Pays Dividends, CMC Forum Participants Agree

PHARMACEUTICAL & BIOTECHNOLOGY QUALITY CONTROL. Early Investment in Characterization Pays Dividends, CMC Forum Participants Agree F-D-C REPORTS FOUNDED 1939 $625 A YEAR www.thegoldsheet.com The Gold Sheet PHARMACEUTICAL & BIOTECHNOLOGY QUALITY CONTROL THE NEWS THIS ISSUE Vol. 40, No. 6 BIOTECH PRODUCT REFERENCE STANDARDS are drawing

More information

Speakers' Portal AUTO16 CME Disclosure Form Results

Speakers' Portal AUTO16 CME Disclosure Form Results Speakers' Portal AUTO16 CME Disclosure Form Results Last Name First Name Roles Relationships Company Name Honoraria/ Expenses Consulting/ Advisory Board Funded Royalties/ Patent Stock Options Ownership/

More information

10th Clinical Performance Metrics & Benchmarking Summit

10th Clinical Performance Metrics & Benchmarking Summit 10th Clinical Performance Metrics & Benchmarking Summit Utilizing Foundational Metrics in a Heavily Data Driven Environment to Ensure High Quality and Efficient Clinical Trials December 4 5, 2013 The Inn

More information

Sponsorship Information

Sponsorship Information Emerging Leaders Conference May 4 6, 017 Grand Hyatt Seattle, WA Preparing Bank Leaders of Tomorrow Sponsorship Information For more information contact Allen King at (415) 35-35 or aking@wib.org Emerging

More information

The room was more than 3/4 full with greater than 150 people in attendance.

The room was more than 3/4 full with greater than 150 people in attendance. Summary The room was more than 3/4 full with greater than 150 people in attendance. The questions were well distributed across all four panelists. All the Panelists were very interactive and were able

More information

Chromatography Column Performance and Data Analysis Success Guide. Hints and Tips for Better Purifications

Chromatography Column Performance and Data Analysis Success Guide. Hints and Tips for Better Purifications Chromatography Column Performance and Data Analysis Success Guide Hints and Tips for Better Purifications This Chromatography Success Guide provides practical advice on preparative chromatography and protein

More information

Erythropoiesis-Stimulating Agents and Beyond: A Review of the Current Landscape of Renal Anemia Research

Erythropoiesis-Stimulating Agents and Beyond: A Review of the Current Landscape of Renal Anemia Research Erythropoiesis-Stimulating Agents and Beyond: A Review of the Current Landscape of Renal Anemia Research Robin Custeau, Principal Analyst, Cardiovascular & Metabolic/Endocrinology Introduction Anemia is

More information

Brand USA 50 States, 5 Territories, 1 United Effort

Brand USA 50 States, 5 Territories, 1 United Effort Brand USA 50 States, 5 Territories, 1 United Effort December 6, 2012 Global Marketing Partner to the Travel Industry Promote the United States as a premier travel destination Established by the Travel

More information

MARKET ENTRY SOLUTIONS IN THE WORLD S LARGEST ECONOMY

MARKET ENTRY SOLUTIONS IN THE WORLD S LARGEST ECONOMY MARKET ENTRY SOLUTIONS IN THE WORLD S LARGEST ECONOMY 0 OVERVIEW Marketing that Works Pte Ltd is an international business and management consulting firm based in Singapore, and in line with our corporate

More information

Nonclinical and Clinical Strategies in First-in-Human Dosing of Large and Small Molecules

Nonclinical and Clinical Strategies in First-in-Human Dosing of Large and Small Molecules Nonclinical and Clinical Strategies in First-in-Human Dosing of Large and Small Molecules April 19-21, 2010 Tutorials: April 18, 2010 April 4-6, 2011 Marriott Bethesda North Hotel & Conference Center,

More information

Cole-Parmer 2012 MCM Award Submission

Cole-Parmer 2012 MCM Award Submission Cole-Parmer 2012 MCM Award Submission 2011/2012 picospin -45 Cross-Channel Product Launch B-to-B Large-Size Company Submitted by: Mary Blase Director, Global Marketing mblase@coleparmer.com (847) 327-5895

More information

Clean Energy Ministerial Update. Jarad Daniels, Policy Group Chair, United States

Clean Energy Ministerial Update. Jarad Daniels, Policy Group Chair, United States Clean Energy Ministerial Update Jarad Daniels, Policy Group Chair, United States 8 th Clean Energy Ministerial (CEM8) in Beijing in June CEM8 side event with energy ministers from Canada, China, Norway,

More information

Our people. Employee engagement and talent retention Compensation/benefits Leadership commitments Organisational effectivenesss

Our people. Employee engagement and talent retention Compensation/benefits Leadership commitments Organisational effectivenesss Our people Our employees are making a valuable difference for patients and are committed to doing their very best work with integrity, courage and passion. Material topics covered in this chapter Employee

More information

INVITATION THE CELEBRATION OF LIFE AND TECHNOLOGY TO EXHIBIT & SPONSOR

INVITATION THE CELEBRATION OF LIFE AND TECHNOLOGY TO EXHIBIT & SPONSOR The 10th ACM SIGGRAPH Conference and Exhibition on Computer Graphics and Interactive Techniques in Asia THE CELEBRATION OF LIFE AND TECHNOLOGY INVITATION TO EXHIBIT & SPONSOR CONFERENCE 27 30 November

More information

Sponsorship Prospectus

Sponsorship Prospectus Change the World with Data Sponsorship Prospectus LAS VEGAS October 2-5, 2017 BERLIN November 13-16, 2017 www.netapp-insight.com 2017 NetApp, Inc. All rights reserved. What is NetApp Insight? NetApp Insight

More information

Biotherapeutic product characterization to support accelerated process development

Biotherapeutic product characterization to support accelerated process development Biotherapeutic product characterization to support accelerated process development Kyle Zingaro, Ph.D. Alexion Pharmaceuticals 2015 Biomanufacturing Technology Summit June 25, 2015 Our Mission: Treating

More information

MARKETS & CUSTOMERS. Progressing globalization. Evolving markets

MARKETS & CUSTOMERS. Progressing globalization. Evolving markets Peptides are used worldwide in medical research. They contribute immensely to the understanding of diseases and have proven to be effective in medicinal products. Today, peptides can be produced at low

More information

Basis for Setting Acceptance Criteria. Basis for setting acceptance criteria

Basis for Setting Acceptance Criteria. Basis for setting acceptance criteria Basis for Setting Acceptance Criteria Representing EBE Brian Withers, Director CMC Regulatory Affairs, Abbott laboratories Basis for setting acceptance criteria Industry considerations: How to allow for

More information

Global Serialisation Developments and the Need for Convergence. Ulrike Kreysa, Vice-President, GS1 Global Office 3 rd June 2015

Global Serialisation Developments and the Need for Convergence. Ulrike Kreysa, Vice-President, GS1 Global Office 3 rd June 2015 Global Developments and the Need for Convergence Ulrike Kreysa, Vice-President, GS1 Global Office 3 rd June 2015 Developments across the world Regulatory bodies need to address Public Health issues one

More information

CALIFORNIA S BIOTECHNOLOGY WORKFORCE TRAINING NEEDS FOR THE 21 st CENTURY

CALIFORNIA S BIOTECHNOLOGY WORKFORCE TRAINING NEEDS FOR THE 21 st CENTURY CALIFORNIA S BIOTECHNOLOGY WORKFORCE TRAINING NEEDS FOR THE 21 st CENTURY Executive Summary Prepared for Applied Biological Technologies Initiative Economic and Workforce Development Program California

More information

New medicines for better health.

New medicines for better health. New medicines for better health. Message from the Chairman of the European Federation of Pharmaceutical Industries and Associations, Japan (EFPIA Japan) EFPIA Japan was established in 2002, and represents

More information

The largest network of harmonized bio/ pharmaceutical GMP product testing labs worldwide, Eurofins BioPharma Product Testing enables companies to

The largest network of harmonized bio/ pharmaceutical GMP product testing labs worldwide, Eurofins BioPharma Product Testing enables companies to The largest network of harmonized bio/ pharmaceutical GMP product testing labs worldwide, Eurofins BioPharma Product Testing enables companies to advance candidates from development through commercialization

More information

WCBP th Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products

WCBP th Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products WCBP 2014 18 th Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products Symposium Co-Chairs Laura Bass, Pfizer, Inc. Arifa Khan, CBER, FDA Marjorie Shapiro, CDER,

More information

CTO s Key International Markets

CTO s Key International Markets CTO International CTO s Key International Markets Americas Primary Markets Canada Mexico Emerging Markets Brazil Columbia Panama Europe, Middle- East, & Africa Primary Markets France & Belgium UK & Ireland

More information

Strategies for building a global healthcare biotechnology company

Strategies for building a global healthcare biotechnology company James A. Geraghty is Senior Vice-President of International Development and is an officer of Genzyme Corporation. In 1993 Genzyme Transgenics was founded and Mr Geraghty served as President and CEO until

More information

INO Therapeutics is now

INO Therapeutics is now INO Therapeutics is now The materials contained herein are a description of our business. They do not purport to be all inclusive or contain all information that you desire. This document includes or may

More information

12th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2015)

12th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2015) 12th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2015) Symposium Co-Chairs: Steven Cohen, Northeastern University Christopher Yu, Genentech, a

More information

ENVIRONMENT. Achieving CONCEPT PAPER

ENVIRONMENT. Achieving CONCEPT PAPER ASIA SIA-EUROPE ENVIRONMENT FORUM 5 TH ROUNDTABLE Achieving Urban Sustainability: Integrated Environmental Management 28-30 November Shenzhen, China CONCEPT PAPER SUMMARY A roundtable discussion among

More information

SAP SuccessFactors Employee Central Payroll Technical and Functional Specifications CUSTOMER

SAP SuccessFactors Employee Central Payroll Technical and Functional Specifications CUSTOMER SAP SuccessFactors Employee Central Payroll Technical and Functional Specifications CUSTOMER TABLE OF CONTENTS KEY FEATURES AND FUNCTIONALITIES... 3 FEATURES AND FUNCTIONS... 3 GLOBALIZATION... 4 REPORTING,

More information

2012 Retained Executive Search: The Associates

2012 Retained Executive Search: The Associates 2012 Retained Executive Search: The Associates Sponsored by the Executive Search Research Consulting Group Underwritten by Strategic Research Solutions January 2013 January 2013 The Executive Search Research

More information

Benefits of Exhibiting. GAPNA 2014 Conference Location. You will...

Benefits of Exhibiting. GAPNA 2014 Conference Location. You will... Exhibit Prospectus Dear Exhibitor The Gerontological Advanced Practice Nurses Association (GAPNA) invites you to join us at our 33rd Annual Conference. GAPNA is a dynamic and emerging professional organization

More information

SmartSpec Plus spectrophotometer

SmartSpec Plus spectrophotometer SmartSpec Plus spectrophotometer Simply Brilliant. The SmartSpec Plus has a more complete range of features and functions than many other benchtop spectrophotometers. It s a complete quantitation package

More information

Tuesday, June 26, 2018 Hyatt regency Hotel, New Brunswick, New Jersey

Tuesday, June 26, 2018 Hyatt regency Hotel, New Brunswick, New Jersey Learn. Connect. Optimize. Tuesday, June 26, 2018 Hyatt regency Hotel, New Brunswick, New Jersey education Forums networking keynote speaker Keynote Speaker: Chairman & CEO of Corning Inc. wendell p. weeks

More information

Ghassem R. Asrar Director, WCRP

Ghassem R. Asrar Director, WCRP Ghassem R. Asrar Director, WCRP Outline Programme and Project Offices Update Major Activities Since JSC-32: conferences/meeting/events major reports WCRP Budget for 2011 and 2012 Activities Planned for

More information

CEM8 CHAIR S SUMMARY: Shared Global Leadership in Clean Energy

CEM8 CHAIR S SUMMARY: Shared Global Leadership in Clean Energy CEM8 CHAIR S SUMMARY: Shared Global Leadership in Clean Energy 1. Ministers and high-level representatives of Australia, Brazil, Canada, People s Republic of China, Chile, Denmark, Finland, France, Germany,

More information

MARKET SCOPING MISSION INFORMATION RAILWAY TECHNOLOGIES & SERVICES 27 NOVEMBER 1 DECEMBER 2017, JAPAN

MARKET SCOPING MISSION INFORMATION RAILWAY TECHNOLOGIES & SERVICES 27 NOVEMBER 1 DECEMBER 2017, JAPAN EU Gateway Business Avenues eu-gateway.eu MARKET SCOPING MISSION INFORMATION RAILWAY TECHNOLOGIES & SERVICES 27 NOVEMBER 1 DECEMBER 2017, JAPAN Are you interested in applying for the Railway Technologies

More information

New medicines for better health.

New medicines for better health. New medicines for better health. Message from the Chairman of the European Federation of Pharmaceutical Industries and Associations, Japan (EFPIA Japan) EFPIA Japan was established in 2002, and represents

More information

EXHIBITION AND SPONSORSHIP

EXHIBITION AND SPONSORSHIP METABOLOMICS JUNE 24-28 2018 SEATTLE, WASHINGTON EXHIBITION AND BROCHURE www.metabolomics2018.org Abstract Deadline: March 2018 WELCOME TO SEATTLE Dear Colleagues, We are delighted to announce that the

More information

Travel Flash Report. Winter 2018

Travel Flash Report. Winter 2018 Travel Flash Report Winter 2018 Summary Key Takeaways Mobile Trends in Travel Cross-device and Last-minute Behavior Focus on Apps Seasonality Appendix 2 Key Takeaways Criteo s deep dive into travel data

More information

E2B(R3): THE INSIDE SCOOP FOR PRODUCT SAFETY TEAMS IN LIFE SCIENCES

E2B(R3): THE INSIDE SCOOP FOR PRODUCT SAFETY TEAMS IN LIFE SCIENCES E2B(R3): THE INSIDE SCOOP FOR PRODUCT SAFETY TEAMS IN LIFE SCIENCES PREPARING FOR E2B(R3) T he electronic transmission of adverse event information to stakeholders, using the International Conference on

More information